Frequent productive cough was experienced by patients with asthma and/or chronic obstructive pulmonary disease (COPD), with symptom prevalence increasing with higher disease severity, according to the ...

A discrete choice experiment found that patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) valued improvement in their daily symptoms more than improvement of exacerbations.

Please provide your email address to receive an email when new articles are posted on . Icenticaftor did not yield a dose response for trough FEV 1 at 12 weeks, but treatment was associated with ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

Please provide your email address to receive an email when new articles are posted on . Severe depression heightened a patient’s likelihood for cough, wheezing, exertional dyspnea, asthma and COPD. As ...

Developing a COPD action plan helps patients improve their confidence and reduces their perceived disease burden. By creating action plans to treat chronic obstructive pulmonary disease (COPD), ...

In 2021, an estimated 14 million adults in the United States reported a diagnosis of chronic obstructive pulmonary disease (COPD), chronic bronchitis, or emphysema. If you’re not sure what the ...